Login to Your Account

Up Against the Big Guys

Local ‘Seoul’: Epirus Approach to Biosimilars Is Portable, Simple

By Randy Osborne
Staff Writer

Friday, August 30, 2013
Start-up Epirus Biopharmaceuticals Inc.’s in-market, for-market approach to making and selling biosimilars in emerging territories could be just the “David” ticket to beat pharma Goliaths that dominate the realm, said Amit Munshi, president and CEO of the Boston-based firm.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription